←
Excelestar Ventures284 posts
Excelestar Ventures avatar

Excelestar Ventures

@Excelestar

We invests in #B2B organizations with disruptive technology that tackles today’s toughest market challenges with a passion for funding minority-led founders.

◷ Joined October 2023▧ 59 Photos and videos
Excelestar Ventures avatar
Excelestar Ventures@Excelestar·31 Dec 2025

2025 was another fantastic year! As we wrap up the year, we’re grateful for our partners, clients, and team who have supported us along the way. We look forward to 2026!

Post attachment
Excelestar Ventures avatar
Excelestar Ventures@Excelestar·22 Dec 2025

The FDA is opening a new pathway for digital health devices to access Medicare payment before traditional authorization. The move seeks to align regulation and reimbursement as digital health tools play a growing role in chronic care management. medtechdive.com/news/fda-dig…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·17 Dec 2025

Regulators are drawing a firmer line between wellness & medical features in wearables. Here's the takeaway from the Whoop and FDA dispute: as wearables move closer to diagnostics, regulatory strategy, clinical validation, and FDA engagement are necessary. medtechdive.com/news/whoop-w…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·12 Dec 2025

Computational modeling and simulation (CM&S) is reshaping clinical evaluation. The FDA expects CM&S to account for nearly 50% of evidence in medical device submissions by 2025, up from 15% just a few years ago. View this @MDDIonline article for more info. mddionline.com/regulatory-qu…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·10 Dec 2025

Through Q3 2025, medtech deal-making reached $1.72B, signaling a rebound from 2024’s full-year total of $2.12B. Q3 alone drove $1.37B, nearly 80% of the year-to-date value, after slow beginnings of $149.1M in Q1 and $192.2M in Q2. Read more in @BioWorld. bioworld.com/articles/726434…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·8 Dec 2025

The surgical robotics market is growing quickly. A new @MassDevice report explains its rapid growth with global market forecasts, a competitive analysis, clinical overview, procedure volumes data, product and pricing updates, and more. Check it out here. massdevice.com/12-things-to-…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·5 Dec 2025

Women are delivering strong business results, but they’re still not being funded. The issue isn’t a lack of ideas. The problem is an outdated financing system still failing to back them. Read more in this @FortuneMagazine article. fortune.com/2025/11/27/finan…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·3 Dec 2025

AI and digital health are expected to continue gaining momentum in 2026. While challenges are anticipated, industry demand and investment remain strong. Digital health is also on the rise, with more IPOs and transactions expected next year. forbes.com/sites/sachinjain/…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·2 Dec 2025

Health tech venture funding is gaining momentum in 2025, with AI driving larger deals. According to @PitchBook, investment in healthcare technology startups has already surpassed 2024 totals through Q3. Read more in this @MedTechDive article. medtechdive.com/news/health-…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·28 Nov 2025

Interesting update in the medtech sector: medtech funding momentum slowed in Q3, dampening expectations that it can achieve its biggest year since 2021. Read this @MedTechDive article to learn why this may be happening. medtechdive.com/news/medtech…

Excelestar Ventures avatar
Excelestar Ventures@Excelestar·26 Nov 2025

Today and every day, we're grateful for the founders and teams we’ve partnered with this year! We’re proud to support several startups who are making waves in the medtech sector, and we look forward to continue working alongside you.

Post attachment
Excelestar Ventures avatar
Excelestar Ventures@Excelestar·20 Nov 2025

Thank you to @MedTechStrat for giving Tasneem Dohadwala the opportunity to speak at Innovation Summit San Diego 2025 this week! During her panel, Tasneem shared her perspective as a medtech investor and advice she would give to startups in the space.

Post attachment